Calendar Lotus Pharmaceutical Co., Ltd.

Equities

1795

TW0001795003

Pharmaceuticals

End-of-day quote Taiwan S.E. Other stock markets 2025-07-09			5-day change	1st Jan Change
209.00 ^TWD	+0.48%		-7.11%	-22.45%

Jun. 19	Lotus Pharmaceutical Unit to Acquire Product Rights in Vietnam for $15.5 Million	MT
Jun. 09	Tranche Update on Lotus Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on April 10, 2025.	CI

Chart calendar Lotus Pharmaceutical Co., Ltd.

db982d7.RqfwbLu64uE88ctzuTdYhh50NiU4NUHUnhW0eKH0fG4.Bc-oBfLi0KhklPIRw2ARsEFCDmhzTXGwrm_rMu2kGlwNkLQzieigowSprA~5550125a4ea3bafb36c75e78d84a83e5

Upcoming events on Lotus Pharmaceutical Co., Ltd.

2025-08-06	Q2 2025 Earnings Release (Projected)
2025-11-05	Q3 2025 Earnings Release (Projected)
2026-03-11	Q4 2025 Earnings Release (Projected)
2026-05-06	Q1 2026 Earnings Release (Projected)

Past events on Lotus Pharmaceutical Co., Ltd.

2025-06-25	Annual General Meeting
2025-06-10 04:38 am	May 2025 Sales and Revenue Release
2025-05-09 08:36 am	Q1 2025 Earnings Release
2025-05-09 05:10 am	April 2025 Sales and Revenue Release
2025-04-08 06:32 am	March 2025 Sales and Revenue Release
2025-03-10 04:44 am	February 2025 Sales and Revenue Release
2025-03-06 06:14 am	Q4 2024 Earnings Release
2025-02-10 03:25 am	January 2025 Sales and Revenue Release
2025-01-10 04:09 am	December 2024 Sales and Revenue Release
2024-12-10 04:02 am	November 2024 Sales and Revenue Release
2024-11-19	Morgan Stanley Asia Pacific Summit
2024-11-17	Macquarie Taiwan Conference
2024-11-12 02:30 am	Q3 2024 Earnings Call
2024-11-07 10:45 am	Q3 2024 Earnings Release
2024-11-07 04:43 am	October 2024 Sales and Revenue Release
2024-10-11 04:45 am	September 2024 Sales and Revenue Release
2024-09-10 04:14 am	August 2024 Sales and Revenue Release
2024-08-15 03:30 am	KGI Securities Investor Conference
2024-08-15 02:00 am	Q2 2024 Earnings Call
2024-08-09 04:05 am	July 2024 Sales and Revenue Release

Past dividends on Lotus Pharmaceutical Co., Ltd.

2024-08-04	Annual 4.647452 TWD
2023-07-04	Other Dividend 3.459921 TWD
2022-08-03	Other Dividend 1.931215 TWD
2021-07-06	Annual 0.35 TWD
2011-09-26	Annual 0.3 TWD
2010-09-07	Annual 0.1 TWD
2009-08-11	Annual 0.2 TWD
2008-08-13	Annual 1 TWD
2007-08-01	Annual 1 TWD
2006-08-02	Annual 0.8 TWD

Annual results

Fiscal Period	December	2022	2023	2024	2025	2026
Net sales Million TWD	Released Forecast Spread	14 633 14 393 1.67%	16 958 17 025 -0.39%	18 584 18 469 0.62%	20 126	21 072
EBITDA Million TWD	Released Forecast Spread	5 048 4 930 2.4%	6 114 6 401 -4.49%	7 303 6 934 5.33%	7 979	7 603
EBIT Million TWD	Released Forecast Spread	4 111 4 164 -1.28%	4 903 5 407 -9.33%	6 020 6 133 -1.84%	7 036	6 344
Earnings before Tax (EBT) Million TWD	Released Forecast Spread	3 940 3 977 -0.93%	5 103 5 139 -0.71%	6 360 5 973 6.48%	6 891	6 313
Net income Million TWD	Released Forecast Spread	3 021 3 099 -2.52%	4 106 4 090 0.37%	5 066 4 810 5.3%	5 526	4 982
EPS TWD	Released Forecast Spread	11,6 12,0 -3.14%	15,7 15,6 1.05%	19,4 18,3 5.93%	20,9	18,9
Announcement Date		14/03/23	15/03/24	07/03/25	-

Quarterly results

Fiscal Period	March	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4
Net sales Million TWD	Released Forecast Spread	4 573 4 498 1.67%	3 419 3 464 -1.28%	4 198 4 237 -0.92%	4 743 5 004 -5.21%	5 234 5 217 0.32%	4 409 4 266 3.36%	4 730 4 456 6.16%	5 172	5 613	4 648	5 028	5 350	5 622	5 086
EBITDA Million TWD	Released Forecast Spread	1 775 1 739 2.05%	466 875 -46.69%	1 572 1 352 16.28%	1 944 2 268 -14.27%	2 439 2 306 5.78%	1 347 1 820 -25.97%	2 066 2 217 -6.8%	2 638	4 154	2 412
EBIT Million TWD	Released Forecast Spread	1 482 1 612 -8.05%	143 696 -79.4%	1 256 1 455 -13.73%	1 633 1 827 -10.63%	2 112 2 052 2.92%	1 019 1 147 -11.13%	1 715 1 348 27.25%	1 858	2 236	1 227	1 490	1 659	1 819	1 386
Earnings before Tax (EBT) Million TWD	Released Forecast Spread	1 566 1 574 -0.51%	508 556 -8.64%	1 306 1 390 -6.03%	1 661 1 776 -6.48%	1 898 2 018 -5.97%	1 494 1 113 34.23%	1 742 1 295 34.49%	1 748	2 207	1 193	1 480	1 653	1 816	1 288
Net income Million TWD	Released Forecast Spread	1 246 1 225 1.73%	400 415 -3.57%	1 036 1 086 -4.56%	1 332 1 398 -4.75%	1 565 1 603 -2.38%	1 133 883 28.22%	1 435 1 028 39.56%	1 389	1 755	947	1 165	1 305	1 436	990
EPS TWD	Released Forecast Spread	4,76 4,69 1.6%	1,53 1,46 4.51%	3,94 4,14 -4.92%	5,09 5,32 -4.29%	5,98 6,09 -1.81%	4,32 3,35 29.15%	5,47 3,90 40.26%	5,26	6,65	3,59	4,42	4,94	5,43	3,77
Announcement Date		10/11/23	15/03/24	11/05/24	08/08/24	07/11/24	07/03/25	09/05/25	-	-	-	-	-	-	-

Upcoming sector events for Lotus Pharmaceutical Co., Ltd.

2025-07-15	GLAND PHARMA LIMITED: Q1 2026 Earnings Release (Projected)
2025-07-16 06:45 am	JOHNSON & JOHNSON: Q2 2025 Earnings Release
2025-07-16	NOVARTIS AG: Q2 2025 Earnings Release
2025-07-17 01:00 am	CAMURUS AB: Q2 2025 Earnings Release
2025-07-17	JUBILANT PHARMOVA LIMITED: Q1 2026 Earnings Release (Projected)
2025-07-18 05:00 am	ORION OYJ: Q2 2025 Earnings Release
2025-07-22	DR. REDDY'S LABORATORIES LIMITED: Q1 2026 Earnings Release
2025-07-22	LABORATORIOS FARMACEUTICOS ROVI, S.A.: Q2 2025 Earnings Release (Projected)
2025-07-22	GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V.: Q2 2025 Earnings Release
2025-07-23 01:00 am	COSMO PHARMACEUTICALS N.V.: Q2 2025 Earnings Release

More events

Past sector events for Lotus Pharmaceutical Co., Ltd.

Today 07:51 pm	BORA PHARMACEUTICALS CO., LTD.: June 2025 Sales and Revenue Release
Today	HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2025 Earnings Release
2025-07-09 04:26 am	YUNGSHIN GLOBAL HOLDING CORPORATION: June 2025 Sales and Revenue Release
2025-07-09 04:06 am	CALIWAY BIOPHARMACEUTICALS CO., LTD.: June 2025 Sales and Revenue Release
2025-07-09 01:58 am	SYNMOSA BIOPHARMA CORPORATION: June 2025 Sales and Revenue Release
2025-07-02 04:08 am	ONENESS BIOTECH CO., LTD.: June 2025 Sales and Revenue Release
2025-06-17 11:45 am	MEDINCELL S.A.: Q4 2025 Earnings Release
2025-06-10 04:38 am	LOTUS PHARMACEUTICAL CO., LTD.: May 2025 Sales and Revenue Release
2025-06-10 01:42 am	CENTER LABORATORIES, INC.: May 2025 Sales and Revenue Release
2025-06-10 01:37 am	SYNMOSA BIOPHARMA CORPORATION: May 2025 Sales and Revenue Release